Episode 325 - Dr. Viral Shah, Professor of Medicine of Endocrinology Indiana University

In this episode of the Diabetes Innovators Series, Rob interviews
Dr. Viral N Shah discussing the Adjust T1D trial, which
investigates the effects of semaglutide, a GLP-1 agonist, on adults
with type 1 diabetes. The trial aims to explore adjunctive
treatment options beyond insulin, focusing on improving glycemic
control, weight loss, and overall patient outcomes. Dr. Shah shares
insights on the trial's design, results, safety profile, and
implications for future diabetes management, emphasizing the need
for continued research and community support. Chapters 00:00
Introduction to the Adjust T1D Trial 03:06 Understanding Type 1
Diabetes and Treatment Options 05:46 Results of the Adjust T1D
Trial 08:54 Safety and Efficacy of Semaglutide 11:45 Implications
for Type 1 Diabetes Management 14:52 Future Research and Community
Impact Resources: Dr. Viral Shah